Lizardi-Cervera J, Aguilar-Zapata D

Idioma: Ingles.
Referencias bibliográficas: 20
Paginas: 40-43
Archivo PDF: 64.61 Kb.

FRAGMENTO

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Méndez-Sánchez N, Chávez-Tapia N, Uribe M. Obesidad y esteatohepatitis no alcohólica. Gac Med Méx 2004; (140): S67-S72.

2. Méndez-Sánchez N, Sánchez-Castillo CP, Villar AR, et al. Relación entre el sobrepeso y obesidad con mortalidad por cirrosis hepática en México. Rev Gastroenterol Mex 2003; 68 (Supl 3): 176.

3. Lizardi-Cervera J, Becerra-Laparra I, Chávez-Tapia N, Ramos-Ostos Me. Uribe M. Hígado graso no alcohólico y síndrome metabólico. Rev Gastroenterol Mex 2006; 71(4): 453-459.

4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346(16): 1221-31.

5. Chávez-Tapia N, Téllez-Ávila F, Valdés-Escárcega M, Montańo-Reyes M, Ramos MH, Lizardi-Cervera J, Uribe M. Metabolic syndrome and estimates of cardiovascular disease in cirrhotic patients. J Dig Dis 2008; 9: 149-155.

6. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008; 51(11): 1947-53.

7. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132: 2169-2180.

8. Pilz S, März W. Free fatty acids as a cardiovascular risk factor. Clin Chem Lab Med 2008; 46 (4):429-34.

9. Yang SQ, Lin HZ, Lande MD, Clemens M, Diehl AM. Obesity increases sensitivity to exotoxin liver injury: Implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997; 94(6): 2557-62.

10. Targher G. Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 2007; 24(1): 1-6.

11. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30(5): 1212-8.

12. Abdeen MB, Chowdhury NA, Hayden MR, Ibdah JA. Nonalcoholic steatohepatitis and the cardiometabolic syndrome. J Cardiometab Syndr 2006; 1(1): 36-40.

13. Targher G, Bertolini L, Rodella S, Lippi G, Franchini M, Zoppini G, Muggeo M, Day CP. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity 2008; 16(6): 1394-9.

14. Sung KC, Ryan MC, Wilson AM, et al. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis 2008 Jul 31.

15. Lizardi-Cervera J, Chávez-Tapia NC, Pérez-Bautista O, Ramos MH, Uribe M. Association among C-reactive protein, Fatty liver disease, and cardiovascular risk. Dig Dis Sci 2007; 52(9): 2375-9.

16. Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, Santorelli G, Valenti L, Maraschi A, Catapano A, Fargion S. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med 2008; 121(1): 72-8.

17. Villanova N, Moscatiello S, Ramillis S. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42: 473-480.

18. Chalasani N, Deeg MA, Crab DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004; 99: 1497-1502.

19. Cikim AS, Topal E, Harputluoglu M, Keskin L, Zengin Z, Cikim K, Ozdemir R, Aladag M, Yologlu S. Epicardial adipose tissue, hepatic steatosis and obesity. J Endocrinol Invest 2007; 30(6): 459-64.

20. Chavez-Tapia N, Tellez-Avila FI, Valdes-Escarcega M, Perez-Bautista O, Lizardi-Cervera J, Méndez-Sánchez N, Sánchez-Avila JF, Ramos MH, Uribe M. Differential risk factor patterns for a positive treadmill test among subjects with and without ultrasound-based fatty liver. Arch Med Sci 2099. In press.